HM Pharma

Year closed	Due by	Filed	Variance	Reference
31-03-2025	31-10-2025	14-10-2025	17 d early	2025-00543394
31-03-2024	31-10-2024	15-10-2024	16 d early	2024-00508333
31-03-2023	31-10-2023	09-10-2023	22 d early	2023-00480810
31-03-2022	31-10-2022	10-10-2022	21 d early	2022-20458272

Metric	This company	Sector median	Position in the sector
Solvency	65.5%	21.2%	better than 85% of 478 sector peers
Net result	€74k	€33k	better than 66% of 476 sector peers
Equity	€287k	€166k	better than 64% of 478 sector peers
Gross operating margin	€196k	€282k	better than 38% of 478 sector peers
Staff costs	€76k	€212k	higher than 22% of 385 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€438k
Fixed assets	21/28	€102k
Tangible fixed assets	22/27	€101k
Financial fixed assets	28	€2k
Current assets	29/58	€335k
Stocks & contracts in progress	3	€124k
Amounts receivable within one year	40/41	€14k
Cash & bank	54/58	€139k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€438k
Equity	10/15	€287k
Contributions / capital	10/11	€1k
Reserves	13	€286k
Amounts payable	17/49	€151k
Amounts payable after one year	17	€40k
Amounts payable within one year	42/48	€100k
Trade debts payable within one year	44	€67k
Income statement
Gross operating margin	9900	€196k
Operating result	9901	€102k
Financial income	75	€3k
Financial charges	65	€4k
Result before taxes	9903	€101k
Income taxes	67/77	€27k
Net result for the period	9904	€74k
Result to be appropriated	9905	€74k

Summary

Parcel (capakey)	Region	Area	Buildings	Height / fl.
35014B0662/00R000	Flanders	1,148 m²	1 · 711 m²	18.3 m · 3 fl.
37011A0468/02B000	Flanders	949 m²	1 · 95 m²	6.9 m · 1 fl.